Coordinator: Joaquín Arribas / Co-coordinator: Federico Rojo
Breast cancer is the type of cancer with greatest incidence among the women in this country and the main cause of death by cancer in European women. Although the survival of patients with this type of cancer has increased over recent years, a small number of them, mainly those with metastasis, continue to be incurable. For this reason there needs to be more in-depth knowledge of the mechanisms involved in its progress and lack of response to current treatments.
The CIBERONC Breast Cancer programme represents a multidisciplinary and collaborative integration of 7 research groups specialising in this pathology to tackle its main problems from basic science to the more clinical aspects.
Main Researcher | Consortium Institution | Regions |
---|---|---|
Ana Lluch | Instituto de Investigación Sanitaria INCLIVA | Valencia |
Atanasio Pandiella | Centro de Invetigación del Cáncer | Salamanca |
Joan Albanell | Hospital del Mar | Cataluña |
Amparo Cano | Universidad Autónoma de Madrid | Madrid |
José Palacios | Hospital Ramón y Cajal | Madrid |
Joaquin Arribas | Instituto de Investigación Oncológica Vall d'Hebrón | Cataluña |
Miguel Martín | Hospital Gregorio Marañón | Madrid |